Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.40
-1.7300-1.76%
Post-market: 96.400.00000.00%16:45 EDT
Volume:760.37K
Turnover:73.30M
Market Cap:24.22B
PE:-12.40
High:97.50
Open:97.50
Low:95.85
Close:98.13
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:0.86
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.17
PE(LYR):-17.47

Loading ...

AppFolio refreshes board leadership and director governance

TIPRANKS
·
Jul 02

EOS updates market on new equity grants to director Dr Andreas Schwer

TIPRANKS
·
Jul 01

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

TIPRANKS
·
Jul 01

De.mem Director Andreas De Wit Increases Direct Shareholding via Off-Market Purchase

TIPRANKS
·
Jun 29

Vaxart Modifies BARDA Contract to Advance Oral COVID-19 Trial

TIPRANKS
·
Jun 27

Biontech Files Form 3 Initial Beneficial Ownership Statement for Director Susanne Schaffert

Reuters
·
Jun 26

De.mem Director Andreas De Wit Increases Equity Stake via Off-Market Share Purchase

TIPRANKS
·
Jun 23

Shionogi Wins Japan Nod for Pediatric Use of COVID-19 Drug XOCOVA

TIPRANKS
·
Jun 19

De.mem updates market on director share acquisition and option changes

TIPRANKS
·
Jun 18

Sector Update: Healthcare Stocks Decline Wednesday Afternoon

MT Newswires Live
·
Jun 18

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Jun 17

Market Chatter: Moderna Looking to Invest in German Production Sites

MT Newswires Live
·
Jun 17

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

GlobeNewswire
·
Jun 16

Berenberg Bank Sticks to Its Buy Rating for SoftwareOne Holding Ltd. (SWON)

TIPRANKS
·
Jun 12

European Equities Traded in US as ADRs Rise in Thursday Trading

MT Newswires Live
·
Jun 11

Energean Director Takes Board Role at National Bank of Greece (Cyprus)

TIPRANKS
·
Jun 10

FOCUS-Cancer vaccines based on mRNA advance, despite US cuts

Reuters
·
Jun 10

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration

GlobeNewswire
·
Jun 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)

TIPRANKS
·
Jun 06

Novavax’s Combo COVID-19 and Flu Shot Trial Reaches Key Milestone for Older Adults

TIPRANKS
·
Jun 06